As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, and in collaboration with the United Kingdom & Ireland Neuroendocrine Tumour Society (UKINETS) we are funding one pump-priming grant in 2024. This grant aims to provide pump-priming funds to support research projects designed to improve outcomes for patients with neuroendocrine cancer. This grant is for £30,000.
The 2024 pump-priming grant is in memory of Azmat Amin and we are so grateful to her family & friends for all their hard work in raising these funds to enable this grant. Azmat tragically died from neuroendocrine cancer at the age of 39 in 2023, leaving a legacy highlighting the importance of research to increase understanding and treatment of the disease.
We are delighted to announce the winner of this year’s pump-priming grant is Professor Rohini Sharma, a consultant in Medical Oncology & Clinical Pharmacology at Imperial College, London.
–
Professor Sharma’s grant project is titled ‘Mathematical descriptors of clinical outcome to PRRT from routine imaging in patients with neuroendocrine tumours.’
Professor Sharma explains what she will be investigating; “Despite the promise of peptide receptor radiotherapy (PRRT), not all patients’ cancers shrink and many do not benefit. It is challenging to predict who will respond to treatment or not. Using artificial intelligence to analyse routine scans before PRRT, we can predict who would benefit from PRRT and who would not, avoiding potentially 8 months of futile treatment. This will move us one step closer to building personalised treatment strategies for each patient.”
We will keep you updated on the progress of this project.